AVP-5

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAVP-5
Drug Alias Namecell surface protein (AviPep)AVP-5
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLupus Erythematosus, SystemicArthritis, RheumatoidLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAvipep
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvipep
Active IndicationsN/A
Inactive IndicationsLupus Erythematosus, SystemicArthritis, RheumatoidLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksN/A